​

Immunocore (IMCR) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

IMCR Stock Forecast

Immunocore (IMCR) stock forecast, based on 14 Wall Street analysts, predicts a 12-month average price target of $47.25, with a high of $60.00 and a low of $36.00. This represents a 41.72% increase from the last price of $33.34.

$25 $34 $43 $52 $61 $70 High: $60 Avg: $47.25 Low: $36 Last Closed Price: $33.34

IMCR Stock Rating

Immunocore stock's rating consensus is Buy, based on 14 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 10 Buy (71.43%), 4 Hold (28.57%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 14 0 4 10 Strong Sell Sell Hold Buy Strong Buy

IMCR Price Target Upside V Benchmarks

TypeNameUpside
StockImmunocore41.72%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts124
Avg Price Target$38.00$46.50$47.25
Last Closing Price$33.34$33.34$33.34
Upside/Downside13.98%39.47%41.72%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 261113--15
Feb, 261123--16
Jan, 2611131-16
Dec, 2511131-16
Nov, 2541031-18
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 19, 2026Mizuho Securities$38.00$32.5116.89%13.98%
Jan 07, 2026Michael YeeUBS$55.00$32.8567.43%64.97%
Nov 10, 2025Sean LaamanMorgan Stanley$36.00$34.534.26%7.98%
Oct 31, 2025Eva Fortea VerdejoWells Fargo$60.00$32.1986.39%79.96%
Mar 07, 2025Morgan Stanley$35.00$29.8017.45%4.98%
Oct 24, 2024David DaiUBS$24.00$32.02-25.05%-28.01%
Sep 16, 2024Justin KimOppenheimer$89.00$33.05169.29%166.95%
Sep 12, 2024Graig SuvannavejhMizuho Securities$72.00$33.44115.31%115.96%
Aug 28, 2024Patrick TrucchioH.C. Wainwright$100.00$35.71180.03%199.94%
Aug 09, 2024Peter LawsonBarclays$66.00$37.9274.05%97.96%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 31, 2025Wells FargoOverweightinitialise
Oct 24, 2024OppenheimerUnderperformUnderperformhold
Oct 24, 2024H.C. WainwrightBuyBuyhold
Oct 24, 2024UBSSellinitialise
Oct 07, 2024NeedhamUnderperformUnderperformhold
Oct 07, 2024GuggenheimNeutraldowngrade
Sep 16, 2024OppenheimerOutperformOutperformhold
Sep 16, 2024Cowen & Co.BuyBuyhold
Aug 28, 2024OppenheimerBuyBuyhold
Aug 28, 2024H.C. WainwrightBuyBuyhold

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-3.13$-0.95$-1.13$-1.02$-0.71---
Avg Forecast$-2.97$-0.33$-0.78$-0.68$-1.14$-1.60$-0.74$0.61
High Forecast$-2.72$-0.30$-0.58$-0.46$-0.14$-0.45$0.69$0.74
Low Forecast$-3.17$-0.41$-0.94$-1.07$-1.78$-3.04$-2.37$0.54
Surprise %5.39%187.88%44.87%50.00%-37.72%---

Revenue Forecast

$0 $150M $300M $450M $600M $750M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$36.48M$144.23M$249.43M$247.77M$400.02M---
Avg Forecast$34.68M$168.66M$247.63M$314.59M$354.46M$379.07M$443.05M$628.29M
High Forecast$36.47M$201.25M$266.94M$318.27M$383.57M$380.94M$454.05M$730.34M
Low Forecast$32.39M$156.95M$219.56M$313.06M$328.98M$377.20M$432.06M$571.66M
Surprise %5.21%-14.48%0.72%-21.24%12.85%---

Net Income Forecast

$-200M $-150M $-100M $-50M $0 $50M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-180.03M$-43.46M$-55.29M$-40.81M$-35.51M---
Avg Forecast$-145.26M$-16.15M$-37.16M$-47.05M$-72.08M$-98.18M$-63.59M$30.04M
High Forecast$-132.81M$-14.70M$-28.29M$-22.35M$-7.05M$-22.24M$33.96M$36.39M
Low Forecast$-155.01M$-20.21M$-46.02M$-52.51M$-87.01M$-148.86M$-115.75M$26.52M
Surprise %23.93%169.06%48.79%-13.27%-50.73%---

IMCR Forecast FAQ

Is Immunocore stock a buy?

Immunocore stock has a consensus rating of Buy, based on 14 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 10 Buy, 4 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Immunocore is a favorable investment for most analysts.

What is Immunocore's price target?

Immunocore's price target, set by 14 Wall Street analysts, averages $47.25 over the next 12 months. The price target range spans from $36 at the low end to $60 at the high end, suggesting a potential 41.72% change from the previous closing price of $33.34.

How does Immunocore stock forecast compare to its benchmarks?

Immunocore's stock forecast shows a 41.72% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Immunocore over the past three months?

  • March 2026: 6.67% Strong Buy, 73.33% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 6.25% Strong Buy, 75.00% Buy, 18.75% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 6.25% Strong Buy, 68.75% Buy, 18.75% Hold, 6.25% Sell, 0% Strong Sell.

What is Immunocore’s EPS forecast?

Immunocore's average annual EPS forecast for its fiscal year ending in December 2026 is $-1.6, marking a 125.35% increase from the reported $-0.71 in 2025. Estimates for the following years are $-0.74 in 2027, and $0.61 in 2028.

What is Immunocore’s revenue forecast?

Immunocore's average annual revenue forecast for its fiscal year ending in December 2026 is $379.07M, reflecting a -5.24% decrease from the reported $400.02M in 2025. The forecast for 2027 is $443.05M, and $628.29M for 2028.

What is Immunocore’s net income forecast?

Immunocore's net income forecast for the fiscal year ending in December 2026 stands at $-98.182M, representing an 176.46% increase from the reported $-35.514M in 2025. Projections indicate $-63.587M in 2027, and $30.04M in 2028.